Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04414020Phase 1Unknown
Phase 1, open-label trial of progesterone in cerebral edema and neuronal injury (2 arms), sponsored by Minia University. Primary endpoint: Number of Participants With craniotomy-Related Adverse Events at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04414020.